🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The hypothesis is that the intranasal use of Pulmozyme will decrease the se...
Status
Withdrawn
Location
Penn State Unicersity
Start Date
2013-07
Trial ID
NCT01155752
Treatments Being Tested
Patients with Sjogren's disease have destruction of the mucus secreting cel...
Status
Withdrawn
Location
University of CT Health Center
Start Date
2011-05
Trial ID
NCT01357447
Treatments Being Tested
The purpose of this study is to evaluate the tolerability and preliminary e...
Status
Terminated
Location
Translational Clinic of Corneal Neurobiology laboratory, Illinois Eye and Ear Infirmary, University of Illinois at Chicago
Start Date
2016-04
Trial ID
NCT02702518
The goal of this project is to rapidly screen promising agents, in the sett...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-07-31
Trial ID
NCT04488081
This is a pilot study to investigate the safety and feasibility of rhDNase1...
Status
Completed
Location
Hamilton General Hospital, Hamilton Health Sciences
Start Date
2020-12-25
Trial ID
NCT04409925
Treatments Being Tested
In this study, the effectiveness of the Dornase Alpha treatment, which is k...
Status
Unknown
Location
Acıbadem Altunizade Hospital
Start Date
2020-05-25
Trial ID
NCT04432987
Treatments Being Tested
This is a Phase 1, single-center, open-label study to evaluate the safety o...
Status
Recruiting
Location
Sourasky Medical Center
Start Date
2026-05
Trial ID
NCT07361224
Treatments Being Tested